Commercial Matura Internship ( MPC Internship)

Job Description

Req #: 1900872
Location: Boudry, Neuchatel, Switzerland
Job Category: Human Resources
Work Location: Route de Perreux 1 2017
Organization: Intern
Employee Status: Full-time
Job Type: Fixed_Term
Other Locations: Switzerland-Neuchatel-Marin

Locations: Switzerland- Boudry – Marin

Who we are?
Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of human health. We value our passion for patients, "quest for innovation, spirit of independence and love of challenge”. With a presence in more than 70 countries and growing - we look for talented people to grow our business, advance our science and contribute to our unique culture.


As part of your Commercial Professional Maturity, we offer you the opportunity to complete your 52-week internship with our company in the following departments:

  • Import and export
  • Supply Chain
  • Drug Safety
  • International Logistics
  • Medical Affairs
  • Compliance Management
  • Development Artwork and Packaging
  • And more

If you are... (your profile)

  • Commercial training with an obligation to complete an internship to obtain the MPC
  • Interested in the pharmaceutical industry and want to help us make patients better lives every day,
  • Dynamic, open-minded and eager to learn,
  • French mother tongue, very good level of English
  • Availability from August 2019

Please send us your application directly,
Then, we will contact you for our speed recruiting that will allow you to meet your future internship teacher... come with your complete file, your joy and your good mood!


About Us

COMMITTED TO IMPROVING THE LIVES OF PATIENTS WORLDWIDE

At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.

"At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients."

There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocytic leukemia (CLL), non-Hodgkin’s lymphoma (NHL), triple-negative breast cancer and pancreatic cancer. As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies.